CSE/MYND (CSE/MYND)

Canadian Securities Exchange: CSE/MYND · CAD

CA$0.07

+0.00 (0.0%)· Recorded snapshot

Market cap	5.2M
Revenue (ttm)	1
Net income (ttm)	-542.6K
EPS (ttm)	-CA$0.01
Shares out	74.5M
Volume	2,000
Beta	0.82

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 1
Net income (ttm): -542.6K
EPS (ttm): -CA$0.01
Market cap: 5.2M

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-29 19:55 UTC

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROEn/a

P25 n/aP50 n/aP75 n/a

ROICn/a

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All CSE/MYND indicators

Market & fundamental data

Available fields

136

Groups with data

Currency

CAD

Showing 136 of 136 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	CAD
Country	Canada
Country code	CA
Earnings date	2027-03-05
Enterprise value	CAD 8.2M
Exchange	Canadian Securities Exchange
Financial currency	CAD
Financial report date	2024-07-31
First seen	2026-05-10
Fiscal year end	October
Industry	Biotechnology
Is primary listing	Yes
ISIN number	CA62857B1094
Last earnings date	2025-09-30
Last refreshed	2026-10-29
Market cap	CAD 5.2M
Next earnings date	2027-03-05
Price	CAD 0.07
Price currency	CAD
Sector	Healthcare
SIC code	2834
Stock price date	2025-05-01
Symbol	cse/MYND
Website	https://www.myndsciences.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings yield	-16.6%
FCF / EV yield	-2.1%
FCF yield	-3.31%
P/S ratio	5,218,346x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Operating margin	-128,598,000%
Pretax margin	-54,256,500%
ROA	-151.46%
ROCE	21.47%
SBC / revenue	2,287,800%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth quarters	8
FCF growth (QoQ)	-99.86%
Net income growth quarters	8

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Depreciation and amortization	CAD 2,280
EBIT	CAD -1.3M
EBITDA	CAD -1.3M
EPS	CAD -0.01
FCF per share	CAD -0.00
Financing cash flow	CAD -50,000
Free cash flow	CAD -172,775
Free cash flow minus SBC	CAD -195,653
Gross profit	CAD -331,778
Investing cash flow	CAD 223,101
Net cash flow	CAD 326
Net income	CAD -542,565
Operating cash flow minus SBC	CAD -195,653
Operating income	CAD -1.3M
Revenue	CAD 1
Stock-based compensation	CAD 22,878

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	-36.38
Book value per share	CAD -0.13
Interest coverage	-5.47
Long-term assets	CAD 105,087
Long-term liabilities	CAD 0
Net cash (debt)	CAD -3M
Net cash / market cap	-57.48%
Piotroski F-Score	2
Property, plant and equipment	CAD 5,087
Shareholders' equity	CAD -6M
Tangible book value	CAD -6M
Tangible book value per share	CAD -0.13
Total assets	CAD 719,718
Total cash	CAD 497
Total debt	CAD 3M
Total liabilities	CAD 6.7M
WACC	7.81%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0
Current assets	CAD 614,631
Current liabilities	CAD 6.7M
Current ratio	0.09
Net working capital	CAD -3.1M
Quick ratio	0.09
Working capital	CAD -6.1M
Working capital turnover	0

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	0.92%
Shareholder yield	0.92%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	CAD 0.05
1D price change	0%
1M price change	133.33%
1M total return	133.33%
1Y price change	100%
1Y return CAGR	100.1%
1Y total return	100%
20-day SMA	CAD 0.08
200-day SMA	CAD 0.04
3M price change	-36.36%
3M total return	-36.36%
3Y price change	-50%
3Y return CAGR	-20.63%
3Y total return	-50%
50-day SMA	CAD 0.08
50-day SMA vs 200-day SMA	50over200
52-week high	CAD 0.14
52-week high date	2024-11-20
52-week low	CAD 0.02
52-week low date	2024-10-30
6M price change	133.33%
6M total return	133.33%
All-time high	CAD 2.50
All-time high date	2021-05-26
All-time low	CAD 0.01
All-time low date	2023-10-20
Average true range (ATR)	CAD 0.02
Average volume	7.5K
Beta (1Y)	0
Beta (2Y)	0.99
Beta (5Y)	0.82
Change from 52-week high	-48.15%
Change from 52-week low	250%
Change from all-time high	-97.2%
Change from all-time low	1,300%
Change from open	0%
Day's gap	0%
Dollar volume	CAD 140
High price	CAD 0.07
Low price	CAD 0.07
Monthly RSI	36.28
Open price	CAD 0.07
Previous close	CAD 0.07
Price vs 150-day SMA	47.37%
Price vs 20-day SMA	-7.04%
Price vs 200-day SMA	56.25%
Price vs 50-day SMA	-10.83%
Relative volume	0.27
RSI	49.1
Sharpe ratio	2.23
Sortino ratio	5.55
Volume	2K
Weekly RSI	51.99
YTD price change	-30%
YTD total return	-30%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Shares change (QoQ)	0%
Shares outstanding	74.5M

Deeper analysis on CSE/MYND

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this CSE/MYND report

Is a complete CSE/MYND research report available?

No complete published report is available for cse/MYND (CSE/MYND) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

CSE/MYND (CSE/MYND)

Price

Financial snapshot

Fair-value bridge

Latest news · CSE/MYND

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All CSE/MYND indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on CSE/MYND

Frequently asked questions